Melatonin Alleviates Renal Injury in Mouse Model of Sepsis

被引：16

作者：

Chen, Liyang ^{[1
]}

Han, Zhijian ^{[2
]}

Shi, Zhiguang ^{[1
]}

Liu, Chao ^{[3
]}

Lu, Qiulun ^{[1
]}

机构：

[1] Nanjing Med Univ, Sch Pharm, Key Lab Cardiovasc & Cerebrovasc Med, Nanjing, Peoples R China

[2] Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing, Peoples R China

[3] Hubei Univ Sci & Technol, Hubei Key Lab Diabet & Angiopathy, Xianning, Peoples R China

来源：

FRONTIERS IN PHARMACOLOGY | 2021年 / 12卷

基金：

中国国家自然科学基金;

关键词：

melatonin; sepsis; ROS (reactive oxygen species); acute kidney injury; renal dysfunction; ACUTE KIDNEY INJURY; RATS;

D O I：

10.3389/fphar.2021.697643

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Melatonin (N-acetyl-5-methoxytryptamine; MLT) has been shown to have a renal-protective effect against kidney injury. However, the mechanisms underlying the protective role of MLT in sepsis-induced renal injury are yet to be revealed. In this study, MLT alleviated renal dysfunction with the increase of BUN (blood urea nitrogen) and SCR (serum creatinine) and reduction of fibrosis in the CLP (cecal ligation puncture) model. RNA-seq analysis showed that MLT repressed the oxidant stress in response to kidney injury. Our in vitro study showed that MLT suppresses LPS-induced accumulation of ROS (reactive oxygen species) production via SOD2 downregulation and Nox4 upregulation in HK-2 cells. Furthermore, we found that MLT alleviated the inflammatory response, with the mRNA-level reduction of Il-1 alpha, Il-1 beta, Mcp-1, and Tgf-beta 1. Taken together, in evaluating the therapeutic effect of MLT on sepsis-induced acute kidney injury, the results showed that MLT alleviated renal damage by regulating the production of ROS.

引用

页数：8

共 22 条

[1] Oxidant stress in kidneys of spontaneously hypertensive rats involves both oxidase overexpression and loss of extracellular superoxide dismutase
Adler, S
Huang, H
[J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2004, 287 (05) : F907 - F913
[2] Aksu U, 2011, CONTRIB NEPHROL, V174, P119, DOI 10.1159/000329249
[3] Acute kidney injury
Bellomo, Rinaldo
Kellum, John A.
Ronco, Claudio
[J]. LANCET, 2012, 380 (9843) : 756 - 766
[4] Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186
[5] Hormesis: A potential strategic approach to the treatment of neurodegenerative disease
Calabrese, Edward J.
Mattson, Mark P.
Dhawan, Gaurav
Kapoor, Rachna
Calabrese, Vittorio
Giordano, James
[J]. METABOLIC AND BIOENERGETIC DRIVERS OF NEURODEGENERATIVE DISEASE: TREATING NEURODEGENERATIVE DISEASES AS METABOLIC DISEASES, 2020, 155 : 271 - 301
[6] Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum
Chen, Dan-Qian
Cao, Gang
Zhao, Hui
Chen, Lin
Yang, Tian
Wang, Ming
Vaziri, Nosratola D.
Guo, Yan
Zhao, Ying-Yong
[J]. THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10
[7] Melatonin prevents sepsis-induced renal injury via the PINK1/Parkin1 signaling pathway
Dai, Wenling
Huang, Haifeng
Si, Linjie
Hu, Shi
Zhou, Liangliang
Xu, Lingling
Deng, Yijun
[J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 44 (04) : 1197 - 1204
[8] Melatonin and its metabolites as copper chelating agents and their role in inhibiting oxidative stress: a physicochemical analysis
Galano, Annia
Medina, Manuel E.
Tan, Dun Xian
Reiter, Russel J.
[J]. JOURNAL OF PINEAL RESEARCH, 2015, 58 (01) : 107 - 116
[9] Acute kidney injury overview: From basic findings to new prevention and therapy strategies
Gonsalez, Sabrina Ribeiro
Cortes, Aline Leal
da Silva, Raquel Costa
Lowe, Jennifer
Prieto, Minolfa C.
Lara, Lucienne da Silva
[J]. PHARMACOLOGY & THERAPEUTICS, 2019, 200 : 1 - 12
[10] Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response
Gustot, Thierry
[J]. CURRENT OPINION IN CRITICAL CARE, 2011, 17 (02) : 153 - 159

← 1 2 3 →